Preferred Label : Panitumumab;

MeSH definition : Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).;

MeSH synonym : Panitumumab Antibody, Human; Human Panitumumab Antibody; ABX-EGF MAb; ABX-EGF Monoclonal Antibody; ABX EGF Monoclonal Antibody; Monoclonal Antibody, ABX-EGF;

MeSH CAS label : Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer;

Wikipedia link : https://en.wikipedia.org/wiki/Panitumumab;

UNII : 6A901E312A;

Details


Main resources

You can consult :

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39581a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39583a-fra.php
Canada
English
French
pharmacovigilance note
patient education handout
panitumumab
infusions, intravenous
antineoplastic agents
stevens-johnson syndrome
epidermal necrolysis, toxic
risk
colorectal neoplasms
neoplasm metastasis
antibodies, monoclonal
Panitumumab

---
http://www.has-sante.fr/portail/jcms/c_2751867/fr/vectibix
2017
false
France
French
IFL protocol
Metastatic colorectal cancer
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
infusions, intravenous
panitumumab
antineoplastic combined chemotherapy protocols
colorectal neoplasms
neoplasm metastasis
KRAS protein, human
colorectal neoplasms
antineoplastic agents
antineoplastic agents
genetic testing
treatment outcome
survival analysis
proto-oncogene proteins
ras proteins
antibodies, monoclonal
antibodies, monoclonal
Proto-Oncogene proteins p21(ras)
antineoplastic combined chemotherapy protocols
camptothecin
camptothecin
leucovorin
fluorouracil
ErbB Receptors
Panitumumab
Panitumumab

---
http://www.has-sante.fr/portail/jcms/c_1763229/fr/vectibix
http://www.has-sante.fr/portail/jcms/c_1763229/fr/vectibix-panitumumab-anticorps-monoclonal
https://www.has-sante.fr/portail/jcms/c_1763229/fr/vectibix-panitumumab-anticorps-monoclonal
2017
false
false
false
false
France
French
infusions, intravenous
evaluation of the transparency committee
antineoplastic agents
antineoplastic agents
colorectal neoplasms
neoplasm metastasis
adult
antineoplastic combined chemotherapy protocols
treatment outcome
genes, ras
mutation
guidelines for drug use
Metastatic colorectal cancer
antibodies, monoclonal
antibodies, monoclonal
Panitumumab
Panitumumab

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/vectibix-3865.html
2016
false
Canada
French
English
evaluation of the transparency committee
infusions, intravenous
antibodies, monoclonal
panitumumab
antineoplastic agents
colorectal neoplasms
treatment outcome
Cost-Benefit analysis
neoplasm metastasis
KRAS protein, human
survival analysis
Tyrosine Kinase Inhibitors
proto-oncogene proteins
ras proteins
drug evaluation
ErbB Receptors
Panitumumab

---
https://www.ema.europa.eu/medicines/human/EPAR/Vectibix
2012
United Kingdom
English
French
syndication feed
Tyrosine Kinase Inhibitors
antibodies, monoclonal
antibodies, monoclonal
colorectal neoplasms
neoplasm metastasis
antineoplastic agents
antineoplastic agents
treatment outcome
drug evaluation
pregnancy
breast feeding
drug labeling
drug approval
drug evaluation, preclinical
panitumumab
antibodies, monoclonal
drug evaluation
summary of product characteristics
package leaflet
ErbB Receptors
Panitumumab
Panitumumab

---
http://www.has-sante.fr/portail/jcms/c_1332065/vectibix
http://www.has-sante.fr/portail/jcms/c_664009/vectibix
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12430_VECTIBIX_17102012_AVIS_CT12430.pdf
2012
France
French
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
infusions, intravenous
panitumumab
antineoplastic combined chemotherapy protocols
colorectal neoplasms
neoplasm metastasis
KRAS protein, human
colorectal neoplasms
antineoplastic agents
antineoplastic agents
genetic testing
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
survival analysis
proto-oncogene proteins
ras proteins
antibodies, monoclonal
antibodies, monoclonal
ErbB Receptors
Panitumumab
Panitumumab

---
http://www.has-sante.fr/portail/jcms/c_1353109/vectibix-panitumumab-anticorps-monoclonal
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-01/vectibix_synthese_ct12430.pdf
2012
France
French
antibodies, monoclonal
antineoplastic agents
neoplasm metastasis
colorectal neoplasms
treatment outcome
antineoplastic combined chemotherapy protocols
survival analysis
panitumumab
guidelines for drug use
Panitumumab

---
https://pgtmsite.files.wordpress.com/2024/01/panitumumab_es_20130619.pdf
2012
false
false
Canada
French
Tyrosine Kinase Inhibitors
panitumumab
antineoplastic agents
colorectal neoplasms
neoplasm metastasis
Evidence-Based medicine
treatment outcome
infusions, intravenous
survival analysis
quebec
drug evaluation
clinical trials, phase iii as topic
disease-free survival
ErbB Receptors
Panitumumab
antibodies, monoclonal

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00161
2011
false
false
false
Canada
drug information
Panitumumab

---
https://rmlg.uliege.be/article/1891
2009
Belgium
journal article
colorectal neoplasms
bevacizumab
cetuximab
antibodies, monoclonal
Panitumumab

---
Nous contacter.
13/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.